Back
Delegates Premium Access

Improvement in the severity of sleep disordered breathing three months after pulmonary vein isolation in patients with persistent atrial fibrillation

Session: Risk factor management in atrial fibrillation
Topic: Rhythm Control, Catheter Ablation
Speaker: Assistant Professor Y. Naruse (Hamamatsu, JP)
Event: EHRA 2026

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Yoshihisa Naruse

Hamamatsu University School of Medicine, Hamamatsu (Japan)
0 follower

6 more presentations in this session

Association of cognitive impairment with dyslipidemia in patients with atrial fibrillation: preliminary results from a prospective registry

Speaker: Doctor S. Mohanty (Austin, US)

Access
Abstract
Like
Thumbnail

GLP-1 receptor agonists and co-agonists for the prevention of atrial fibrillation in overweight or obesity: a meta-analysis of randomized controlled trials

Speaker: Doctor P. Karakasis (Thessaloniki, GR)

Access
Abstract
Like
Thumbnail

Change in sleep apnea parameters in patients with atrial fibrillation undergoing pulmonary vein isolation: interim analysis of the AAHIi study

Speaker: Doctor P. Basiukiewicz (Grodzisk Mazowiecki, PL)

Access
Abstract
Like
Thumbnail

SGLT2 inhibitors and the risk of atrial fibrillation recurrence within one year after radiofrequency ablation

Speaker: Doctor M. Velescu (Cluj Napoca, RO)

Access
Abstract
Like
Thumbnail

Impact of mobile health-detected airflow obstruction on periprocedural symptom severity and quality of life in patients with atrial fibrillation undergoing first-time ablation.

Speaker: Ms K. Ignaczak (Warsaw, PL)

Access
Abstract
Like
Thumbnail

Access the full session

Risk factor management in atrial fibrillation

Speakers: Assistant Professor Y. Naruse, Doctor S. Mohanty, Doctor P. Karakasis, Doctor P. Basiukiewicz, Doctor M. Velescu...
Access
Like
Thumbnail

About the event

Image

EHRA 2026

12 April - 14 April 2026

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources
novartis Explore sponsored resources